Rawalpindi Institute of Cardiology is a non-profit tertiary level cardiac hospital located on Rawal Road in Rawalpindi, of the Punjab province of Pakistan. Established in 2012, RIC has nearly 50 departments which provide health facilities to several parts of the country.

There are 272 beds in Rawalpindi Institute of Cardiology.

During the past decade, Rawalpindi Institute of Cardiology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rawalpindi Institute of Cardiology" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Rawalpindi Institute of Cardiology" with 1 trials as a collaborator and "University of Cape Town" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Rawalpindi Institute of Cardiology" are "Heart Diseases" (1 trials), "Heart Failure" (1 trials), "Myocardial Infarction" (1 trials), "Myocardial Ischemia" (1 trials) and "Myocardial Revascularization" (1 trials). Many other conditions were trialed in "Rawalpindi Institute of Cardiology" in a lesser frequency.

Most popular intervention types in "Rawalpindi Institute of Cardiology" are "Other" (4 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aerobic exercises" (1 trials), "Colchicine" (1 trials), "Combined training" (1 trials), "Continuous Aerobic (Mild intensity Exercise)" (1 trials) and "Continuous Aerobic Moderate Intensity Exercise" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rawalpindi Institute of Cardiology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Rawalpindi Institute of Cardiology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Rawalpindi Institute of Cardiology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rawalpindi Institute of Cardiology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".